Biologic Drug Product Sourcing Center

Biologic Drug Product Sourcing Center

Biological products range widely from allergenics, blood components, gene and cell therapy, recombinant therapeutic proteins, vaccines, etc.

Products are composed of various substances, and isolations from natural sources - human, animal, or microorganism – can be produced and characterized by advanced technologies and methods. Aseptic facilities and special equipment are often required, in contrast to most conventional (small-molecule) drugs. And with the growing demand for cell and gene, and other biologic expertise to advance cutting-edge science and programs, drug product development and manufacture will continue to be in great demand.

How can we help?

Looking for help with your Biologic Drug Product project? If you're searching for information or a supplier, let Life Science Connect lend you a hand.

Submit A Question

Biologic Drug Product CMOs

AbbVie
AbbVie

When you engage AbbVie Contract Manufacturing, you're getting more than a CMO. You access the capabilities of a highly experienced biopharmaceutical company. You know that your project will benefit from our broad range of capabilities and portfolio of state-of-the-art facilities. Most of all, you know that your project will be reliably served by a business with a trusted reputation for innovation, reliability, compliance and delivery.

Capabilities

Abzena
Abzena

Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule.

Biologic Drug Product CMO - AGC Biologics
AGC Biologics

AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) committed to delivering the highest standard of service and collaboration to our clients and partners as we work side-by-side to help bring their products to patients across the globe. We offer world-class development and manufacturing services of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA) viral vectors, and genetically engineered cells.


Have questions about selecting the right CMO?

The Life Science Connect team can help. We'll match your needs with the right companies.

Contact us via email for assistance.


Biologic Drug Product CMO - Ajinomoto Bio-Pharma Services
Ajinomoto Bio-Pharma Services

Working with Ajinomoto Bio-Pharma Services, you get a trusted CDMO partner that has the power to make your every challenge our own, sharing your unwavering tenacity and dedication from pre-clinical program to commercial successes. We leverage our broad range of capabilities and services at our sites in Belgium, India, Japan, and the US to support your program goals.

Capabilities

Biologic Drug Product CMO - Catalent
Catalent

Catalent is a global leader in providing integrated services, superior drug delivery technologies and manufacturing solutions to help life science innovators develop and launch successful pharmaceuticals, biologics and consumer health products.

Capabilities

Biologic Drug Product CMO - FUJIFILM Diosynth Biotechnologies
FUJIFILM Diosynth Biotechnologies

FUJIFILM Diosynth Biotechnologies is a CDMO Partner for Life. We combine technical leadership in cell culture, microbial fermentation and advanced therapies with world class cGMP manufacturing facilities and superior program management to advance tomorrow's medicines.


Biologic Drug Product CMO - IDT Biologika
IDT Biologika

IDT Biologika is a global CDMO for Innovative Vaccines, Cell & Gene Therapeutics and Aseptic Fill-Finish of other biologics. We offer clients a single source CDMO partner at our sites in Germany and the USA, with seamless end-to-end solutions and the ability to nimbly scale projects from development through to commercialization. This includes Process Development, Drug Substance Manufacturing, Sterile Dosage Fill-Finish, Labelling & Packaging, Quality Control & Analytics.

Biologic Drug Product CMO - INCOG BioPharma Services
INCOG BioPharma Services

INCOG has been designed and built from decades of experience with a clear purpose: to deliver better CDMO services in the injectable drug product space. The company's service offering includes filling drug product into vials, syringes, and cartridges. INCOG also offers support services to include formulation development, analytical development, stability testing and storage, and final inspection, labeling, packaging, and device assembly.

Biologic Drug Product CMO - KBI Biopharma
KBI Biopharma

KBI Biopharma, Inc., a JSR Life Sciences company, is a leading global CDMO providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, KBI delivers robust process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs.

Capabilities


Biologic Drug Product CMO - Kymanox Corporation
Kymanox Corporation

Kymanox is a life science professional services organization that offers engineering, scientific, and compliance support to companies exclusively in the biotechnology, pharmaceutical, medical device, and combination product industries. With its diverse team, Kymanox helps clients navigate commercialization challenges that arise throughout a product's lifecycle – from early development to post-market commercialization – with optimized safety, quality, efficacy, and accessibility.

Biologic Drug Product CMO - Lonza
Lonza

Lonza is a preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. Our unparalleled breadth of offerings enables our customers to commercialize their discoveries and innovations in the healthcare industry.

Biologic Drug Product CMO - MilliporeSigma
MilliporeSigma

We have established synergy between production and testing within one company supporting early development through commercial production, proven FDA/EMA compliant quality systems for commercial release of approved products, and a history of successfully navigating the commercial regulatory pathways.

Capabilities


Biologic Drug Product CMO - Nanoform
Nanoform

Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners to improve the lives of patients globally by overcoming drug development and delivery challenges through its game-changing nanoforming technologies, novel formulation capabilities and GMP manufacturing facilities. The company's dedicated, multi-disciplinary team has a combined experience of launching 100+ medicines.

Biologic Drug Product CMO - PCI Pharma Services
PCI Pharma Services

PCI Pharma Services is an integrated full service provider, a proven and trusted partner to leading companies in the global healthcare industry. We offer unparalleled expertise and experience in taking compounds from the earliest stages of development through to successful commercialization, delivering speed-to-market and commercial success for our customers.

Small Molecule Drug Product CMO - Pfizer
Pfizer CentreOne

Pfizer CentreOne is a global CDMO embedded within Pfizer and a leading supplier of specialty APIs.

Working together with our customers, we combine our knowledge with open dialogue to solve challenges.


Biologic Drug Product CMO - National Resilience, Inc
Resilience US, Inc.

Resilience is a manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption. Founded in 2020, the company is building a sustainable network of high-tech, end-to-end manufacturing solutions with the aim to ensure the medicines of today and tomorrow can be made quickly, safely, and at scale. Resilience seeks to offer regulatory capabilities and flexible and adaptive facilities to serve partners of all sizes.

Biologic Drug Product CMO - Samsung Biologics
Samsung Biologics

Samsung Biologics is a full-service provider offering development and cGMP manufacturing services. We deliver a broad range of services from development and manufacturing to fill and finish, covering both clinical molecules and commercial products.

Biologic Drug Product CMO - Simtra BioPharma Solutions
Simtra BioPharma Solutions

Simtra BioPharma Solutions partners with pharmaceutical and biotech companies to support their commercialization objectives by providing scientific expertise, sterile contract manufacturing solutions, and customized support services needed to meet the unique challenges that parenteral products face.


Biologic Drug Product CMO - Singota Solutions
Singota Solutions

Specializing in small batch aseptic fill/finish of vials, syringes, and cartridges, Singota Solutions is focused on moving products through the drug development pipeline faster—with agility, accountability, and transparency.

Biologic Drug Product CMO - Societal<sup>™</sup> CDMO
Societal CDMO

Societal CDMO is a bi-coastal CDMO with capabilities spanning pre-Investigational New Drug (IND) development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus in small molecules. With an expertise in solving complex manufacturing problems, Societal is a leading CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market.